NCT01824602 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder Status TERMINATED Phase PHASE2
NCT01822678 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder Status COMPLETED Phase PHASE2
NCT01765127 An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest) Status COMPLETED Phase N/A
NCT01731119 Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents Status COMPLETED Phase PHASE2
NCT01710163 Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients Status UNKNOWN Phase PHASE4
NCT01655030 Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression Status COMPLETED Phase NA
NCT01588457 Sequential Multiple Assignment Treatment for Bipolar Disorder Status COMPLETED Phase PHASE4
NCT01575561 This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Status COMPLETED Phase PHASE3
NCT01570959 Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions Status COMPLETED Phase NA
NCT01570894 Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT01567527 Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients Status COMPLETED Phase PHASE3
NCT01495156 Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania Status WITHDRAWN Phase PHASE4
NCT01395992 Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692) Status COMPLETED Phase PHASE3
NCT01358357 Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Status COMPLETED Phase PHASE3
NCT01206517 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) Status COMPLETED Phase PHASE1
NCT01059539 Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00982020 Study in Adolescents With Schizophrenia or Bipolar Disorder Status COMPLETED Phase PHASE4